Predictors of BAT Positivity in Chronic Spontaneous Urticaria and Clinical Characteristics of Patients

Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2018.12.151
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Omalizumab Treatment in Patients With Chronic Spontaneous Urticaria

Bőrgyógyászati és Venerológiai Szemle
2015English

Clinical Management of Urticaria Using Omalizumab: The First Licensed Biological Therapy Available for Chronic Spontaneous Urticaria

Journal of the European Academy of Dermatology and Venereology
DermatologyInfectious Diseases
2016English

Cost of Treatment of Chronic Spontaneous Urticaria in Turkey

Health
2016English

Economic Burden of Chronic Spontaneous Urticaria and Psoriasis: Patients Perspective From Europe & Us

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

High Prevalence of Mental Disorders and Emotional Distress in Patients With Chronic Spontaneous Urticaria

Acta Dermato-Venereologica
DermatologyMedicine
2011English

Chronic Spontaneous Urticaria: Implications of Subcutaneous Inflammatory Cell Infiltration in an Intractable Clinical Course

Journal of Allergy and Clinical Immunology
AllergyImmunology
2017English

Sociodemographic and Clinical Characteristics, Causal Factors and Evolution of a Group of Patients With Chronic Urticaria-Angioedema

Sao Paulo Medical Journal
Medicine
2007English

Efficacy of Omalizumab in Treatment-Resistant Chronic Spontaneous Urticaria

Asim, Allerji, Immunoloji
Respiratory MedicinePulmonaryAllergyImmunology
2018English

Transient Hair Loss in Patients With Chronic Spontaneous Urticaria Treated With Omalizumab

European Annals of Allergy and Clinical Immunology
AllergyImmunology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy